Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-13 Sale |
2025-02-14 6:57 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
5,844 | $116.69 | $681,914 | 551,775 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 6:56 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
2,274 | $118.37 | $269,167 | 519,074 (Direct) |
View |
| 2025-01-31 Sale |
2025-02-04 5:58 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
2,707 | $152.92 | $413,967 | 522,172 (Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 7:03 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
146,105 | $149.46 | $21,836,503 | 514,596 (Direct) |
View |
| 2024-09-27 Sale |
2024-10-01 4:09 pm |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
2,654 | $20.68 | $54,885 | 8,392 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 5:43 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,832 | $133.02 | $376,700 | 649,655 (Direct) |
View |
| 2024-02-13 Purchase |
2024-02-15 4:02 pm |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
53 | $19.12 | $1,013 | 5,060 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 7:21 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
5,314 | $138.74 | $737,271 | 506,962 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:21 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,707 | $140.69 | $380,845 | 502,188 (Direct) |
View |
| 2024-01-08 Sale |
2024-01-10 4:31 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
167,858 | $133.02 | $22,328,417 | 561,777 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 8:08 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
9,328 | $107.4 | $1,001,816 | 499,754 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:28 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
29,044 | $102.9 | $2,988,758 | 491,365 (Direct) |
View |
| 2023-01-31 Sale |
2023-02-02 5:19 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,707 | $110.08 | $297,997 | 465,278 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 7:00 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
10,984 | $80.54 | $884,674 | 462,844 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:17 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
12,888 | $116.26 | $1,498,368 | 573,850 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:16 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
308,250 | $110.22 | $33,973,877 | 441,071 (Direct) |
View |
| 2020-11-12 Sale |
2020-11-16 6:16 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
3,390 | $90.78 | $307,748 | 441,071 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-07 7:29 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
3,390 | $118.91 | $403,101 | 438,021 (Direct) |
View |
| 2020-04-24 Sale |
2020-04-28 8:41 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,906 | $99.45 | $289,016 | 434,971 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Exercise |
2025-02-14 6:57 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
10,979 | $0 | 551,775 (Direct) |
View |
| 2025-02-08 Exercise |
2025-02-12 6:56 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
4,318 | $0 | 519,074 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 5:58 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
5,141 | $0 | 522,172 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 7:03 pm |
N/A 2025-02-03 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
146,105 | $0 | 514,596 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 7:03 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Director |
146,105 | $32.99 | 514,596 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:22 pm |
N/A 2034-06-12 |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
17,957 | $0 | 23,017 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 5:43 pm |
N/A 2034-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
135,059 | $0 | 649,655 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-14 5:17 pm |
N/A 2026-02-05 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,778 | $35.99 | 512,052 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-14 5:17 pm |
N/A 2027-02-06 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
2,312 | $43.24 | 512,052 (Direct) |
View |
| 2024-01-08 Exercise |
2024-01-10 4:31 pm |
N/A 2024-01-16 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
167,858 | $19.59 | 561,777 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 5:55 pm |
N/A 2033-06-20 |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
15,020 | $0 | 15,020 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:11 pm |
N/A 2033-02-13 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
155,162 | $0 | 155,162 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:50 pm |
N/A 2032-06-23 |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
21,412 | $0 | 21,412 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 7:51 pm |
N/A 2032-01-31 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
160,614 | $0 | 160,614 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-25 8:01 pm |
N/A 2031-06-24 |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
9,728 | $0 | 9,728 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:19 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
113,863 | $0 | 113,863 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:17 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
120,878 | $0 | 573,850 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:16 pm |
N/A 2022-01-12 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
143,449 | $8.66 | 441,071 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:16 pm |
N/A 2023-01-10 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
164,801 | $8.65 | 441,071 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 8:24 pm |
N/A 2030-06-24 |
Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director |
13,953 | $0 | 13,953 (Direct) |
View |